【正文】
uditWHO國(guó)際藥品管理當(dāng)局會(huì)議 世界衛(wèi)生組織WHOICDRA World Health Organization 預(yù)料外不良事件WHO Unexpected Adverse Event 受試和參比試劑UAE Test and Reference ProductR Standard Operating Procedure 受試者識(shí)別代碼SOP Subject Identification Code 申辦研究者SIC SponsorInvestigator 受試者入選表SI Subject Enrollment Log 原始數(shù)據(jù)核準(zhǔn)SEL Source Data Verification國(guó)家食品藥品監(jiān)督管理局SDV 受試者日記SFDA Subject Diary 嚴(yán)重不良反應(yīng)SD Serious Adverse Reaction 統(tǒng)計(jì)分析計(jì)劃SAR Statistical Analysis Plan 嚴(yán)重不良事件SAP Serious Adverse Event 現(xiàn)場(chǎng)評(píng)估SAE Site Assessment 質(zhì)量控制RA Quality Control制藥業(yè)統(tǒng)計(jì)學(xué)家協(xié)會(huì)QA Premarket Approval (Application) 產(chǎn)品許可證PMA Product License 國(guó)家衛(wèi)生研究所(美國(guó))PI National Institutes of Health 新化學(xué)實(shí)體NIH New Drug Entity 新藥申請(qǐng)NEC New Drug Application 日本衛(wèi)生福利部NDA Ministry of Health and Welfare 英國(guó)藥品監(jiān)督局MHW Medicines Control Agency上市許可證MCA互動(dòng)語(yǔ)音應(yīng)答系統(tǒng)MA 體外診斷IVRS In Vitro Diagnostic 機(jī)構(gòu)審查委員會(huì)IVD Institutional Review Board 新藥臨床研究IRB Investigational New Drug 獨(dú)立倫理委員會(huì)IND Indep